Cooley represents pharma company in $425 million note offering
Cooley guided Carlsbad-based Isis Pharmaceuticals Inc. in the company’s note offering of $425 million worth of convertible senior notes due 2021. Combined with the offering, the drug discovery and development company will use a portion of the proceeds to repurchase $140 million worth of principal outstanding notes with a 2.75 percent interest due 2019.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
